Evidence map›Paper›PMID 26733702›Full record

ArticleHealth affairs (Project Hope)2016

Medicaid Tobacco Cessation: Big Gaps Remain In Efforts To Get Smokers To Quit.

Leighton Ku, Brian K Bruen, Erika Steinmetz, Tyler Bysshe

Abstract read
In one paragraph

Article in Health affairs (Project Hope), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2019
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Leighton KuLeighton Ku (lku@gwu.edu) is a professor of health policy and management and director of the Center for Health Policy Research at the George Washington University, in Washington, D.C.
Brian K BruenBrian K. Bruen is a lead research scientist and lecturer in the Department of Health Policy and Management at the George Washington University.
Erika SteinmetzErika Steinmetz is a senior research scientist in the Milken Institute School of Public Health at the George Washington University.
Tyler ByssheTyler Bysshe is a senior research assistant in the Milken Institute School of Public Health at the George Washington University.

Funding

Medicaid Tobacco Cessation: State Policies and EffectivenessR15CA176600 · NCI · GEORGE WASHINGTON UNIVERSITY · PI KU, LEIGHTON · 2014 to 2014
$475k
NCI NIH HHS 1R15CA176600-01A1NCI NIH HHS R15 CA176600
6 · The paper itself

Abstract

Medicaid enrollees are about twice as likely as the general US population to smoke tobacco: 32 percent of people in the program identify themselves as smokers. This article provides the first data about the effectiveness of state Medicaid programs in promoting smoking cessation. Our analysis of Medicaid enrollees' use of cessation medications found that about 10 percent of current smokers received cessation medications in 2013. Every state Medicaid program covers cessation benefits, but the use of these medications varies widely, with the rate in Minnesota being thirty times higher than that in Texas. Most states could increase their efforts to help smokers quit, working with public health agencies, managed care plans, and others. In 2013 Medicaid spent $103 million on cessation medications-less than 0.25 percent of the estimated cost to Medicaid of smoking-related diseases. Additionally, states that have not expanded Medicaid eligibility in the wake of the Affordable Care Act have higher smoking prevalence and lower utilization rates of cessation medication, compared to expansion states. Given these factors, nonexpansion states will have a greater public health burden related to smoking. Medicaid and public health agencies should work together to make smoking cessation a priority for Medicaid beneficiaries.

Indexed as

Health Care CostsAdultBupropionDatabases, FactualDrug UtilizationFemaleHumansMaleMedicaidMiddle AgedPatient Protection and Affordable Care ActRetrospective StudiesRisk AssessmentTobacco Use CessationUnited StatesBupropionMedicaidPublic HealthTobacco/Smoking

Identifiers

PMID26733702
PMCPMC4705858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.